Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-13,639
Closed -$683K 573
2025
Q4
$683K Buy
13,639
+8,440
+162% +$406K 0.17% 184
2025
Q3
$255K Sell
5,199
-7,643
-60% -$392K 0.06% 359
2025
Q2
$665K Buy
12,842
+7,204
+128% +$331K 0.22% 132
2025
Q1
$264K Buy
+5,638
New +$291K 0.13% 228

Other funds holding SNV

Farringdon Capital's SNV Position: Q1 2026 in Review

Farringdon Capital sold out of Synovus (SNV) in Q1 2026, closing a stake of 13,639 shares — an estimated $683K sold.

Farringdon Capital first reported a position in SNV in Q1 2025 and held it in 4 quarters. The position peaked at $683K in Q4 2025. 1 fund tracked by Wall St. Rank holds SNV as of Q1 2026.

  • Farringdon Capital reported no remaining Synovus position as of Q1 2026 after selling out during the quarter.
  • Farringdon Capital sold 13,639 Synovus shares in Q1 2026, an estimated $683K.
  • Farringdon Capital first reported a position in Synovus in Q1 2025 and held it in 4 quarters.
  • Farringdon Capital's Synovus position peaked at $683K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Synovus as of Q1 2026.

Based on Farringdon Capital's 13F filing for Q1 2026, filed 15 May 2026.